Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Updates in Pediatric Atopic Dermatitis : Episode 7

Opinion

Video

February 24, 2025

New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Roflumilast

Author(s):

Lisa Swanson, MD, FAAD,Lawrence Eichenfield, MD

Panelists discuss the topical treatment option roflumilast for pediatric atopic dermatitis, exploring its mechanism of action, efficacy, safety, and potential role in managing the condition.

EP: 1.Updates in Pediatric Atopic Dermatitis

EP: 2.Pathophysiology and Role of Type 2 Inflammation in Pediatric Atopic Dermatitis

EP: 3.Talking to Patients and Families About Type 2 Inflammatory Conditions

EP: 4.Unpacking the Atopic Dermatitis Burden of Disease With Patients and Families

EP: 5.Unique Challenges in Managing Atopic Dermatitis in Pediatric Patients

EP: 6.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Ruxolitinib

Now Viewing

EP: 7.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Roflumilast

Video content above is prompted by the following:

Now let’s talk about some of the latest treatment advances in pediatric atopic dermatitis, starting with topicals. Discuss the topical treatment options that are newly available or on the horizon, including how they work to treat atopic dermatitis as well as efficacy and safety: